-
Standardized Whole-Blood Stimulation in Immunometabolism
2026-08-14
The Phenomics protocol by Zhao and colleagues establishes a standardized whole-blood platform for testing how metabolic interventions alter stimulus-specific immune responses. Its main contribution is the integration of controlled immune stimulation, pathway-directed metabolic modulation, and cytokine quantification in fresh human blood, creating a practical framework for reproducible cohort studies.
-
Chemerin–cNTS Signaling Raises Sympathetic Activity
2026-08-14
Hao and colleagues show that chemerin signaling in the caudal nucleus tractus solitarius increases renal sympathetic nerve activity, arterial pressure, and heart rate through CMKLR1-dependent NADPH oxidase activation and superoxide production. Pharmacological pathway testing further implicates NMDA, rather than AMPA/kainate, receptor transmission in the downstream paraventricular nucleus, clarifying how an adipokine can influence central cardiovascular control.
-
EZ Cap™ Cy5 EGFP mRNA (5-moUTP) Guide
2026-08-13
Build a dual-readout mRNA delivery assay that separates cellular uptake from productive translation. EZ Cap™ Cy5 EGFP mRNA (5-moUTP) combines direct Cy5 tracking with EGFP expression for nanoparticle validation, macrophage targeting, and faster troubleshooting.
-
FH1 for iPS-Derived Hepatocyte Maturation
2026-08-13
FH1 is a practical small-molecule option for improving functional readouts during iPS cell differentiation to hepatocytes, with reported gains in albumin secretion, CYP3A4, colony morphology, and reduced AFP. This guide translates those findings into a controlled iHep workflow and shows how the reference study’s light-regulated translation strategy can inform, but not replace, FH1 assay design.
-
Balsalazide disodium: Workflows for IBD Research
2026-08-12
Balsalazide disodium supports colon-focused inflammation research, from water-based assay preparation to radiolabeled imaging in ulcerative colitis models. Its practical differentiation is the combination of a 5-aminosalicylic acid prodrug design, aqueous solubility, and a reference workflow that achieved high ulcerated-colon uptake in mice.
-
Torin2: Separating mTOR Signaling From Cell Death
2026-08-12
Torin2 is a potent mTOR inhibitor for dissecting pathway suppression, transcriptional stress, and apoptosis without conflating these outcomes. This interpretation-first guide connects recent Pol II findings with practical assay design and medullary thyroid carcinoma research.
-
Phosphotungstic Acid Negative Stain: Form to Function
2026-08-11
Phosphotungstic Acid Negative Stain Solution (2%) is more than an electron microscopy stain: it is a practical morphology checkpoint for virology and macromolecular research. This guide explains how to interpret structural evidence alongside mechanistic assays, using conserved coronavirus spike glycans as a scientifically grounded example.
-
Wnt-C59 Workflows for PORCN Inhibition
2026-08-11
Wnt-C59 provides a high-potency route to test whether Wnt-ligand secretion drives a phenotype, from cholangiocarcinoma growth assays to exosome-mediated osteogenesis. This practical guide connects PORCN inhibition with dose design, Wnt/β-catenin readouts, donor–recipient exosome experiments, and troubleshooting.
-
DOT1L Inhibition Potentiates Lenalidomide in Myeloma
2026-08-10
A 2025 Cancer Letters study shows that DOT1L inhibition reprograms type I interferon and STING-associated innate immune signaling in multiple myeloma cells while suppressing IRF4-MYC activity. The work provides a mechanistic rationale for combining epigenetic intervention with lenalidomide, although validation beyond cell-line and dependency-dataset evidence remains necessary.
-
Concanavalin A Targets Conserved Coronavirus Glycans
2026-08-09
The reference study identifies conserved high-mannose N-glycans near the coronavirus spike S2′ cleavage site as a broad antiviral vulnerability. Using fusion, pseudovirus, authentic-virus, biochemical, and animal models, the authors show that concanavalin A blocks spike activation and reduces hCoV-NL63 disease in mice.
-
Z-DEVD-FMK: A Practical Caspase-3 Inhibitor Guide
2026-08-08
Z-DEVD-FMK helps researchers test whether caspase-dependent apoptosis drives a phenotype, while its additional activity against other caspases and calpain demands carefully designed controls. This workflow-focused guide covers melanoma apoptosis assays, neuronal injury models, formulation, interpretation, and troubleshooting.
-
O-GlcNAc–HUWE1–TfR1 Axis in Preeclampsia
2026-08-07
A 2026 study identifies an O-GlcNAc–HUWE1–TfR1 pathway linking trophoblast ferroptosis with defective syncytialization in preeclampsia. Its data suggest that increasing O-GlcNAc modification stabilizes HUWE1, promotes TfR1 ubiquitination and degradation, limits iron uptake, and improves pregnancy-related phenotypes in mice.
-
Ruxolitinib (INCB018424): Immune Microenvironment Reprogramm
2026-08-07
Explore how Ruxolitinib (INCB018424) drives immune microenvironment reprogramming in oncological and myeloproliferative disorder research. This in-depth analysis highlights mechanistic insights, protocol guidance, and new directions for immune profiling beyond conventional JAK-STAT assays.
-
Biotin-16-UTP: Precision RNA Labeling for Interaction Studie
2026-08-06
Biotin-16-UTP streamlines high-fidelity RNA labeling for robust detection, purification, and interactome mapping. Its proven performance empowers advanced applications such as RNA-protein interaction assays and lncRNA localization workflows, delivering reproducibility and sensitivity where it counts most.
-
Cyclosporin: Integrating Structural Biology and Immunosuppre
2026-08-06
Explore the multifaceted role of Cyclosporin in immunosuppression and mitochondrial research. This article uniquely bridges structural dynamics with practical assay choices, offering advanced insights for researchers using Cyclosporin A in cellular and translational models.